Literature DB >> 25425327

Evaluating the validity of clinical codes to identify cataract and glaucoma in the UK Clinical Practice Research Datalink.

Elizabeth M Kang1, Simone P Pinheiro, Tarek A Hammad, Adel Abou-Ali.   

Abstract

PURPOSE: The aim of this study is to determine (i) the positive predictive value (PPV) of an algorithm using clinical codes to identify incident glaucoma and cataract events in the Clinical Practice Research Datalink (CPRD) and (ii) the ability to capture the correct timing of these clinical events.
METHODS: A total of 21,339 and 5349 potential cataract and glaucoma cases, respectively, were identified in CPRD between 1 January 1990 and 31 December 2010. Questionnaires were sent to the general practitioners (GP) of 1169 (5.5%) cataract and 1163 (21.7%) glaucoma cases for validation. GPs were asked to verify the diagnosis and the timing of the diagnosis and to provide other supporting information.
RESULTS: A total of 986 (84.3%) valid cataract questionnaires and 863 (74.2%) glaucoma questionnaires were completed. 92.1% and 92.4% of these used information beyond EMR to verify the diagnosis. Cataract and glaucoma diagnoses were confirmed in the large majority of the cases. The PPV (95% CI) of the cataract and glaucoma Read code algorithm were 92.0% (90.3-93.7%) and 84.1% (81.7-86.6%), respectively. However, timing of diagnosis was incorrect for a substantial proportion of the cases (20.3% and 32.8% of the cataract and glaucoma cases, respectively) among whom 30.4% and 49.2% had discrepancies in diagnosis timing greater than 1 year.
CONCLUSIONS: High PPV suggests that the algorithms based on the clinical Read codes are sufficient to identify the cataract and glaucoma cases in CPRD. However, these codes alone may not be able to accurately identify the timing of the diagnosis of these eye disorders. Ltd.
Copyright © 2014 John Wiley & Sons, Ltd.

Entities:  

Keywords:  clinical practice research datalink; eye disorders; pharmacoepidemiology; read codes; validation of cataract; validation of glaucoma

Mesh:

Year:  2014        PMID: 25425327     DOI: 10.1002/pds.3726

Source DB:  PubMed          Journal:  Pharmacoepidemiol Drug Saf        ISSN: 1053-8569            Impact factor:   2.890


  5 in total

1.  Validity of code based algorithms to identify primary open angle glaucoma (POAG) in Veterans Affairs (VA) administrative databases.

Authors:  K S Biggerstaff; B J Frankfort; S Orengo-Nania; J Garcia; E Chiao; J R Kramer; D White
Journal:  Ophthalmic Epidemiol       Date:  2017-09-25       Impact factor: 1.648

2.  Validity of ankylosing spondylitis diagnoses in The Health Improvement Network.

Authors:  Maureen Dubreuil; Christine Peloquin; Yuqing Zhang; Hyon K Choi; Robert D Inman; Tuhina Neogi
Journal:  Pharmacoepidemiol Drug Saf       Date:  2016-01-13       Impact factor: 2.890

Review 3.  Respiratory effect of beta-blocker eye drops in asthma: population-based study and meta-analysis of clinical trials.

Authors:  Daniel R Morales; Tobias Dreischulte; Brian J Lipworth; Peter T Donnan; Cathy Jackson; Bruce Guthrie
Journal:  Br J Clin Pharmacol       Date:  2016-06-17       Impact factor: 4.335

4.  Data-driven identification of ageing-related diseases from electronic health records.

Authors:  Valerie Kuan; Helen C Fraser; Melanie Hingorani; Spiros Denaxas; Arturo Gonzalez-Izquierdo; Kenan Direk; Dorothea Nitsch; Rohini Mathur; Constantinos A Parisinos; R Thomas Lumbers; Reecha Sofat; Ian C K Wong; Juan P Casas; Janet M Thornton; Harry Hemingway; Linda Partridge; Aroon D Hingorani
Journal:  Sci Rep       Date:  2021-02-03       Impact factor: 4.379

5.  Cataract in patients with diabetes mellitus-incidence rates in the UK and risk factors.

Authors:  Claudia Becker; Cornelia Schneider; Samuel Aballéa; Clare Bailey; Rupert Bourne; Susan Jick; Christoph Meier
Journal:  Eye (Lond)       Date:  2018-02-01       Impact factor: 3.775

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.